clear
Wednesday September 20th, 2017 9:37PM

US clears first 'living drug' for tough childhood leukemia

By The Associated Press
Related Articles
  Contact Editor

WASHINGTON (AP) — Opening a new era in cancer care, the Food and Drug Administration on Wednesday approved the first treatment that genetically engineers patients' own blood cells into an army of assassins to seek and destroy childhood leukemia.

The CAR-T cell treatment developed by Novartis Pharmaceuticals and the University of Pennsylvania is the first type of gene therapy to hit the U.S. market — and one in a powerful but expensive wave of custom-made "living drugs" being tested against blood cancers and some other tumors, too.

FDA called the approval historic.

"This is a brand new way of treating cancer," said Dr. Stephan Grupp of Children's Hospital of Philadelphia, who treated the first child with CAR-T cell therapy — a girl who'd been near death but now is cancer-free for five years and counting. "That's enormously exciting."

Novartis said it would charge $475,000 for the treatment, made from scratch for every patient. But, the company said there would be no charge if the patient didn't show a response within a month.

CAR-T treatment uses gene therapy techniques not to fix disease-causing genes but to turbocharge T cells, immune system soldiers that cancer too often can evade. Researchers filter those cells from a patient's blood, reprogram them to harbor a "chimeric antigen receptor" that zeroes in on cancer, and grow hundreds of millions of copies. Returned to the patient, the revved-up cells can continue multiplying to fight disease for months or years.

It's a completely different way to harness the immune system than popular immunotherapy drugs called "checkpoint inhibitors" that treat a variety of cancers by helping the body's natural T cells better spot tumors. CAR-T cell therapy gives patients stronger T cells to do that job.

"We're entering a new frontier in medical innovation with the ability to reprogram a patient's own cells to attack a deadly cancer," said FDA Commissioner Scott Gottlieb.

This first use of CAR-T therapy is aimed at patients desperately ill with a common pediatric cancer — acute lymphoblastic leukemia, or ALL — that strikes more than 3,000 children and young adults in the U.S. each year. While most survive, about 15 percent relapse despite today's best treatments, and their prognosis is bleak.

In a key study of 63 advanced patients, 83 percent went into remission. Importantly, it's not clear how long that benefit lasts: Some patients did relapse months later. The others still are being tracked to see how they fare long-term.

Still, "a far higher percentage of patients go into remission with this therapy than anything else we've seen to date with relapsed leukemia," said Dr. Ted Laetsch of the University of Texas Southwestern Medical Center, one of the study sites. "I wouldn't say we know for sure how many will be cured yet by this therapy. There certainly is a hope" that some will be.

Most patients suffered side effects that can be grueling, even life-threatening. An immune overreaction called "cytokine release syndrome" can trigger high fevers, plummeting blood pressure and in severe cases organ damage, requiring special care to tamp down those symptoms without blocking the cancer attack. Also Wednesday, the FDA designated a treatment for those side effects.

"This is remarkable technology," said Dr. Mikkael Sekeres of the American Society of Hematology. But, he cautioned, "It isn't a panacea."

Among concerns, sometimes leukemia can develop resistance, and sometimes patients worsen while waiting for their new cells, said Sekeres, who directs the Cleveland Clinic's leukemia program and wasn't involved with CAR-T testing.

"Unfortunately leukemia grows so rapidly that it can evade even the smartest of our technologies," he added.

For some patients, the new CAR-T therapy might replace bone marrow transplants that cost more than half a million dollars, noted Grupp, who led the Novartis study.

"I don't want to be an apologist for high drug prices in the U.S.," Grupp stressed. But if it's the last treatment they need, "that's a really significant one-time investment in their wellness, especially in kids who have a whole lifetime ahead of them."

Initially, Novartis' CAR-T version — to be sold under the brand name Kymriah (kihm-REYE'eh) — will be available only through certain medical centers specially trained to handle the sophisticated therapy and its side effects. Patients' collected immune cells will be frozen and shipped to a Novartis factory in New Jersey that creates each dose, a process the company says should take about three weeks.

While this first use of CAR-T therapy only is aimed at a few hundred U.S. patients a year — relapsed ALL patients up to age 25 — it's being tested as a treatment for thousands more. Kite Pharma's similar CAR-T brand, developed by the National Cancer Institute, is expected to win approval later this year to treat aggressive lymphoma, and Juno Therapeutics and other companies are studying their own versions against blood cancers including multiple myeloma.

Scientists around the country also are trying to make CAR-T therapies that could fight more common solid tumors such as brain, breast or pancreatic cancers — a harder next step.

___

AP Medical Writer Linda A. Johnson in Trenton, New Jersey, contributed to this report.

This Associated Press series was produced in partnership with the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.

  • Associated Categories: U.S. News, Associated Press (AP), AP National News, AP Online National News, Top U.S. News short headlines, Top General short headlines, AP Online Headlines - Washington, AP Health, AP Health - Children's Health, AP Business, AP Business - Corporate News, AP Business - Industries, AP Business - Health Care, AP Technology News
© Copyright 2017 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
AP Was There: Mourners gather for Princess Diana's funeral
AP Was There: Mourners gather for Princess Diana's funeral
10:53AM ( 11 minutes ago )
Motorists, gawkers line up to see new bridge in Scotland
Motorists and gawkers jammed onto Scotland's new bridge over the Firth of Forth, anxious to see the new expanse on its first full day of operation
10:52AM ( 11 minutes ago )
Matt Damon goes mini in Venice opener "Downsizing"
"Downsizing" has generated jumbo-sized buzz at the Venice Film Festival _ not least as viewers debate how to describe it
10:51AM ( 13 minutes ago )
Associated Press (AP)
Latest: Official can't say if flooded homes will be rebuilt
An official says it's too soon to say if the thousands of Houston-area homes flooded by Harvey's torrential rains can be rebuilt
10:36AM ( 27 minutes ago )
Posts, tweets spread widely as the Harvey missing are sought
Photos with pleas for help in finding the missing from Harvey are being posted, cut-and-pasted, and retweeted by the thousands as desperate family members seek loved ones who they fear might be dead, but may only have a dead phone
10:24AM ( 39 minutes ago )
Latest: Flood officials: Houston-area reservoirs near crest
Officials say nearly all Houston-area waterways inundated by Harvey's record rainfall have crested, but that water levels continue to rise in two flood-control reservoirs
10:20AM ( 43 minutes ago )
AP National News
Harvey swamps evacuee shelter on Texas, Louisiana border
A sodden Texas coastal community is becoming increasingly isolated as Harvey-fed rains flood major roadways and swamp a shelter for the displaced
9:25AM ( 1 hour ago )
US economic growth upgraded to 3 percent rate in Q2
US economic growth upgraded to 3 percent rate in April-June quarter, strongest pace in more than 2 years
9:11AM ( 1 hour ago )
French police hunt for girl, 9, who vanished at a wedding
French police are widening their search for a 9-year-old girl who disappeared during a wedding in the Alps, combing woods and streams and questioning more potential witnesses
8:43AM ( 2 hours ago )
Top General short headlines
Prosecutors expect to charge German nurse with more killings
German prosecutors say they expect to bring new charges against a nurse serving a life sentence for two murders after determining he might have killed another 84 people, if not more
8:42AM ( 1 day ago )
Flooding disrupts care at Houston hospital, cancer center
Officials began to clear space at one of the nation's busiest trauma centers ahead of Harvey's aftermath
3:05AM ( 1 day ago )
Public health dangers loom in Harvey-hit areas
The muddy floodwaters now soaking through dry wall, carpeting, mattresses and furniture will pose a massive cleanup challenge with potential public health consequences
7:32PM ( 1 day ago )
AP Health
Colorado bus aide sentenced for assaulting autistic student
A former Colorado school bus aide who pleaded guilty to assaulting an autistic student on his way to and from school was sentenced to 20 months in jail
4:58PM ( 4 days ago )
FDA OKs Pfizer drug for rare, fast-killing type of leukemia
FDA approves new medicine for use against a rare, rapidly progressing blood cancer after other treatments have failed
5:35PM ( 1 week ago )
35 children die in north Indian hospital in 3 days
Parents of at least 35 children who have died in a state-run hospital in northern India over the past three days have alleged that the fatalities were due to the lack of a sufficient oxygen supply in the children's ward
12:44PM ( 2 weeks ago )
AP Health - Children's Health
German foreign minister says European unity key to future
Germany's foreign minister says Europe must stand together if it wants to stay relevant as its population shrinks, the U.S. focuses more Asia, and China's influence expands
10:32AM ( 32 minutes ago )
Stocks are mixed as tech companies rise and energy falls
US stocks are little changed as technology companies rise, helped by strong earnings from chipmaker Analog Devices, while energy companies fall
10:20AM ( 43 minutes ago )
Jordan, Iraq reopen border crossing, vital to trade
Jordan and Iraq reopen their only border crossing after a two-year closure
10:00AM ( 1 hour ago )
AP Business
AP Was There: Mourners gather for Princess Diana's funeral
AP Was There: Mourners gather for Princess Diana's funeral
10:53AM ( 11 minutes ago )
The Latest: Osteen defends initial move to not open church
Joel Osteen is defending the decision not to open his Houston megachurch as a shelter during the initial flooding from Harvey in the face of withering criticism on social media
10:50AM ( 13 minutes ago )
Top EU lawmaker says Brexit delays raise need for transition
The European Parliament's top Brexit official says that the slow progress of the divorce proceedings between the EU and Britain has made sure that the need of a prolonged transition period after the March 2019 deadline is gaining ever more traction
10:49AM ( 14 minutes ago )
S. Korean court says worker's rare disease linked to Samsung
South Korea's Supreme Court says a former worker in a Samsung LCD factory who was diagnosed with multiple sclerosis should be recognized as having an occupationally caused disease
10:45AM ( 19 minutes ago )
US-led coalition says it may hit IS evacuees in Syria
The U.S.-led coalition says it may strike a convoy of IS militants that evacuated the Lebanon border headed toward eastern Syria under a controversial agreement brokered by Hezbollah
10:44AM ( 19 minutes ago )